Join today and get instant access to all test results and research.
Mylan New Zealand has recalled two batches of its EpiPen 300mcg Adrenaline Auto-Injectors, used to treat allergic emergencies. The devices could fail to activate due to a defective part, which could put your life at risk.
Two devices from a production run of 80,000 have reportedly failed overseas. 1794 devices from this run have been distributed in New Zealand.
Devices with batch numbers 5FA665 and 5FA6652 are affected by the recall and have an expiry date of Apr 17.
Check your device’s batch number and expiry date. These can be found on the end of the carton or on the label of the pen.
Return your affected EpiPens to your pharmacist, who will replace them for free. Keep your current EpiPen until you get a replacement and use it if required.
For more information, call 0800 335 336.
This information is available to Consumer members only.